AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
GLIMEPIRIDE, METFORMIN HYDROCHLORIDE in Zimbabwe
1 product registered with MCAZ — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GLIMEPIRIDE / METFORMIN HYDROCHLORIDE IMPACT TABLET, COATED; ORAL | 2026/17.7/7287 | SANOFI - AVENTIS | active | 4 Feb 2031 |
GLIMEPIRIDE, METFORMIN HYDROCHLORIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing GLIMEPIRIDE, METFORMIN HYDROCHLORIDE, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track GLIMEPIRIDE, METFORMIN HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.